Protection against Experimental Melioidosis following Immunisation with a Lipopolysaccharide-Protein Conjugate
Melioidosis is a severe infectious disease caused by Burkholderia pseudomallei. It is refractory to antibiotic treatment and there is currently no licensed vaccine. In this report we detail the construction and protective efficacy of a polysaccharide-protein conjugate composed of B. pseudomallei lip...
Saved in:
| Main Authors: | Andrew E. Scott, Sarah A. Ngugi, Thomas R. Laws, David Corser, Claire L. Lonsdale, Riccardo V. D’Elia, Richard W. Titball, E. Diane Williamson, Timothy P. Atkins, Joann L. Prior |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2014/392170 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Approach to melioidosis
by: Ella M. Meumann, et al.
Published: (2024-06-01) -
Differential Toll-Like Receptor-Signalling of Burkholderia pseudomallei Lipopolysaccharide in Murine and Human Models.
by: Tassili A F Weehuizen, et al.
Published: (2015-01-01) -
Melioidosis molecular diagnostics: An update
by: Prachi Gangil, et al.
Published: (2025-12-01) -
Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.
by: Sharon J Peacock, et al.
Published: (2012-01-01) -
Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme
by: Esra Çakar, et al.
Published: (2025-02-01)